SEI Investments’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $55.2K | Sell |
60,090
-11,105
| -16% | -$13.4K | ﹤0.01% | 3167 |
|
|
2025
Q4 | $91.1K | Sell |
71,195
-2,389
| -3% | -$3.21K | ﹤0.01% | 3024 |
|
|
2025
Q3 | $95.7K | Buy |
73,584
+7,990
| +12% | +$10.5K | ﹤0.01% | 2722 |
|
|
2025
Q2 | $78.8K | Buy |
65,594
+2,055
| +3% | +$2.28K | ﹤0.01% | 2707 |
|
|
2025
Q1 | $68.6K | Sell |
63,539
-2,230
| -3% | -$3.13K | ﹤0.01% | 2650 |
|
|
2024
Q4 | $115K | Buy |
65,769
+2,272
| +4% | +$4.23K | ﹤0.01% | 2560 |
|
|
2024
Q3 | $123K | Buy |
63,497
+32,843
| +107% | +$64.3K | ﹤0.01% | 2534 |
|
|
2024
Q2 | $54.2K | Buy |
30,654
+372
| +1% | +$909 | ﹤0.01% | 2583 |
|
|
2024
Q1 | $82K | Sell |
30,282
-518
| -2% | -$1.25K | ﹤0.01% | 2524 |
|
|
2023
Q4 | $68K | Sell |
30,800
-2,999
| -9% | -$6.4K | ﹤0.01% | 2541 |
|
|
2023
Q3 | $98K | Buy |
33,799
+1,873
| +6% | +$4.9K | ﹤0.01% | 2515 |
|
|
2023
Q2 | $61.6K | Sell |
31,926
-252
| -0.8% | -$497 | ﹤0.01% | 2607 |
|
|
2023
Q1 | $62.8K | Buy |
32,178
+4,502
| +16% | +$8.89K | ﹤0.01% | 2613 |
|
|
2022
Q4 | $32.4K | Sell |
27,676
-1,156
| -4% | -$1.42K | ﹤0.01% | 2499 |
|
|
2022
Q3 | $32K | Buy |
28,832
+855
| +3% | +$1.29K | ﹤0.01% | 2637 |
|
|
2022
Q2 | $25K | Sell |
27,977
-2,196
| -7% | -$5.43K | ﹤0.01% | 2627 |
|
|
2022
Q1 | $86K | Buy |
30,173
+8,850
| +42% | +$30.6K | ﹤0.01% | 2518 |
|
|
2021
Q4 | $67K | Buy |
21,323
+444
| +2% | +$2.08K | ﹤0.01% | 2564 |
|
|
2021
Q3 | $131K | Buy |
20,879
+590
| +3% | +$3.88K | ﹤0.01% | 2491 |
|
|
2021
Q2 | $122K | Buy |
20,289
+5,353
| +36% | +$28.6K | ﹤0.01% | 2501 |
|
|
2021
Q1 | $94K | Hold |
14,936
| – | – | ﹤0.01% | 2444 |
|
|
2020
Q4 | $94K | Sell |
14,936
-1,955
| -12% | -$12.8K | ﹤0.01% | 2415 |
|
|
2020
Q3 | $127K | Sell |
16,891
-146,133
| -90% | -$1.01M | ﹤0.01% | 2312 |
|
|
2020
Q2 | $659K | Buy |
163,024
+694
| +0.4% | +$2.42K | ﹤0.01% | 1736 |
|
|
2020
Q1 | $408K | Buy |
162,330
+25,226
| +18% | +$82.9K | ﹤0.01% | 1804 |
|
|
2019
Q4 | $477K | Sell |
137,104
-14,687
| -10% | -$51.7K | ﹤0.01% | 1953 |
|
|
2019
Q3 | $708K | Sell |
151,791
-28,451
| -16% | -$224K | ﹤0.01% | 1728 |
|
|
2019
Q2 | $2.22M | Buy |
180,242
+25,627
| +17% | +$326K | 0.01% | 1290 |
|
|
2019
Q1 | $2.06M | Buy |
154,615
+134,532
| +670% | +$1.42M | 0.01% | 1296 |
|
|
2018
Q4 | $175K | Buy |
20,083
+4,199
| +26% | +$32.7K | ﹤0.01% | 2065 |
|
|
2018
Q3 | $121K | Sell |
15,884
-8,940
| -36% | -$63.6K | ﹤0.01% | 2044 |
|
|
2018
Q2 | $148K | Buy |
24,824
+3,085
| +14% | +$17.6K | ﹤0.01% | 2156 |
|
|
2018
Q1 | $127K | Buy |
21,739
+2,121
| +11% | +$13.9K | ﹤0.01% | 2051 |
|
|
2017
Q4 | $115K | Sell |
19,618
-2,050
| -9% | -$11.2K | ﹤0.01% | 2091 |
|
|
2017
Q3 | $109K | Buy |
21,668
+14,932
| +222% | +$62.8K | ﹤0.01% | 2055 |
|
|
2017
Q2 | $27K | Buy |
6,736
+1,062
| +19% | +$5.04K | ﹤0.01% | 2379 |
|
|
2017
Q1 | $32K | Buy |
5,674
+2,693
| +90% | +$17.1K | ﹤0.01% | 2236 |
|
|
2016
Q4 | $22K | Sell |
2,981
-783
| -21% | -$4.92K | ﹤0.01% | 2319 |
|
|
2016
Q3 | $30K | Buy |
3,764
+430
| +13% | +$3.95K | ﹤0.01% | 2179 |
|
|
2016
Q2 | $30K | Buy |
3,334
+602
| +22% | +$5.66K | ﹤0.01% | 2066 |
|
|
2016
Q1 | $22K | Buy |
2,732
+1,355
| +98% | +$9.77K | ﹤0.01% | 2030 |
|
|
2015
Q4 | $15K | Buy |
1,377
+1,376
| +137,600% | +$13.5K | ﹤0.01% | 2162 |
|
|
2015
Q3 | $0 | Buy |
+1
| New | +$16 | ﹤0.01% | 2538 |
|
Other funds holding LAB
CC
MCO
LFCM
VCM
HBWM
SEI Investments's LAB Position: Q1 2026 in Review
SEI Investments reduced its Standard BioTools (LAB) stake by 16% in Q1 2026, selling an estimated $13.4K and leaving 60,090 shares worth $55.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3167.
SEI Investments first reported a position in LAB in Q3 2015 and has held it in 43 quarters since. The position peaked at $2.22M in Q2 2019. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.
- SEI Investments held 60,090 shares of Standard BioTools worth $55.2K as of Q1 2026.
- SEI Investments sold 11,105 Standard BioTools shares in Q1 2026, an estimated $13.4K.
- Standard BioTools made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #3167 holding.
- SEI Investments first reported a position in Standard BioTools in Q3 2015 and has held it in 43 quarters since.
- SEI Investments's Standard BioTools position peaked at $2.22M in Q2 2019.
- 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.
Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.